Physiomics Plc Total Assets
Physiomics Plc total assets. Based on the latest financial reports, Physiomics Plc (PYC) holds total assets worth GBX558.00K GBX (≈ $67.89 USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PYC company net worth for the company's overall valuation and market capitalisation.
Total Assets of Physiomics Plc (2001–2025)
Total assets of Physiomics Plc from 2001 to 2025. This chart illustrates how Physiomics Plc's total assets have evolved over time, based on quarterly financial data. See Physiomics Plc (PYC) stock price for real-time trading data and today's change.
Physiomics Plc - Asset Composition Analysis
Physiomics Plc Total Assets Breakdown (June 2025)
Physiomics Plc total assets breakdown as of June 2025. Physiomics Plc's total assets of GBX558.00K consist of 98.2% current assets and 1.8% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 51.7% |
| Accounts Receivable | GBX363.28K | 40.7% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX3.28K | 0.4% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Physiomics Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Physiomics Plc short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Physiomics Plc's current assets represent 98.2% of total assets in 2025, an increase from 52.5% in 2001.
- Cash Position: Cash and equivalents constituted 51.7% of total assets in 2025, up from 34.5% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 46.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 40.7% of total assets.
Physiomics Plc Competitors by Total Assets
Key competitors of Physiomics Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL Ltd
AU:CSL
|
Australia | AU$39.54 Billion |
|
Genmab A/S
CO:GMAB
|
Denmark | Dkr7.02 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653
|
China | CN¥7.88 Billion |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
USA | $462.21 Million |
|
Bachem Holding AG
SW:BANB
|
Switzerland | CHF2.11 Billion |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
USA | $521.90 Million |
|
SOLENO THERAPEUT. DL-001
F:6XC
|
Germany | €563.83 Million |
Physiomics Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.30 | 4.77 | 11.35 |
| Quick Ratio | 3.30 | 4.77 | 11.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX380.00K | GBX400.00K | GBX1.26 Million |
Physiomics Plc - Advanced Valuation Insights
This section examines the relationship between Physiomics Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.34 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 111.1% |
| Total Assets | GBX892.03K |
| Market Capitalization | $23.44K USD |
Valuation Analysis
Below Book Valuation: The market values Physiomics Plc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Physiomics Plc's assets grew by 111.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Physiomics Plc (2001–2025)
The table below shows the annual total assets of Physiomics Plc from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX892.03K ≈ $108.53 |
+111.08% |
| 2024-06-30 | GBX422.60K ≈ $51.42 |
-37.34% |
| 2023-06-30 | GBX674.39K ≈ $82.05 |
-39.54% |
| 2022-06-30 | GBX1.12 Million ≈ $135.71 |
-15.71% |
| 2021-06-30 | GBX1.32 Million ≈ $161.01 |
-8.52% |
| 2020-06-30 | GBX1.45 Million ≈ $176.00 |
+108.34% |
| 2019-06-30 | GBX694.29K ≈ $84.47 |
-15.15% |
| 2018-06-30 | GBX818.23K ≈ $99.56 |
+97.08% |
| 2017-06-30 | GBX415.18K ≈ $50.51 |
+36.88% |
| 2016-06-30 | GBX303.31K ≈ $36.90 |
-19.94% |
| 2015-06-30 | GBX378.87K ≈ $46.10 |
+55.15% |
| 2014-06-30 | GBX244.19K ≈ $29.71 |
-35.82% |
| 2013-06-30 | GBX380.47K ≈ $46.29 |
-54.71% |
| 2012-06-30 | GBX840.10K ≈ $102.22 |
-3.21% |
| 2011-06-30 | GBX868.00K ≈ $105.61 |
-5.86% |
| 2010-06-30 | GBX922.00K ≈ $112.18 |
+235.27% |
| 2009-06-30 | GBX275.00K ≈ $33.46 |
+141.23% |
| 2008-06-30 | GBX114.00K ≈ $13.87 |
-62.38% |
| 2007-06-30 | GBX303.00K ≈ $36.87 |
+107.53% |
| 2006-06-30 | GBX146.00K ≈ $17.76 |
-72.30% |
| 2005-06-30 | GBX527.00K ≈ $64.12 |
+466.67% |
| 2004-06-30 | GBX93.00K ≈ $11.32 |
+17.72% |
| 2003-06-30 | GBX79.00K ≈ $9.61 |
-43.17% |
| 2001-06-30 | GBX139.00K ≈ $16.91 |
-- |
About Physiomics Plc
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour pred… Read more